{"id":6895,"date":"2025-09-08T06:53:06","date_gmt":"2025-09-08T04:53:06","guid":{"rendered":"https:\/\/fgk-group.com\/?post_type=news-events-news&p=6895"},"modified":"2025-11-20T11:44:56","modified_gmt":"2025-11-20T10:44:56","slug":"martin-krauss-on-how-ctis-endangers-the-future-of-clinical-studies-in-europe","status":"publish","type":"news-events-news","link":"https:\/\/fgk-group.com\/de\/news-konferenzen\/news\/martin-krauss-on-how-ctis-endangers-the-future-of-clinical-studies-in-europe\/","title":{"rendered":"Martin Krauss on how CTIS endangers the future of clinical studies in Europe"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t21\/Feb\/23\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t

Martin Krauss on how CTIS endangers the future of clinical studies in Europe<\/h1>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

One year after its launch, the CTIS portal suffers from serious deficiencies, severely impairing the application procedure for clinical studies in all of Europe.<\/p>

Since end of January and after a one year transition period, approval for new clinical trials of medicinal products in Europe can only be done via the electronic CTIS portal of EMA. CTIS is part of EU Regulation 536\/2014 (CTR) and was installed to facilitate and expedite the approval process in Europe.<\/p>

Instead, it\u2019s insufficient functionality now threatens the entire European landscape of drug research. The German magazine transkript published an article, which shows alarming figures: It is to be feared that the dysfunctionality of the CTIS portal will lead to a potentially permanent migration of drug trials to other regions of the world and in the worst case to significant deterioration in the supply situation of seriously ill patients with innovative drugs.
An alliance of industry organizations, including the BVMA (German Association for Contract Research Organizations), where FGK\u2019s Managing Director Martin Krauss is President, urge rapid action by politics to save the competitiveness of Europe as a research location:\u00a0Klinische Studien im Sinkflug<\/a>\u00a0\u00a0<\/strong> (\u00a9|transkript 1-2023)<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

One year after its launch, the CTIS portal suffers from serious deficiencies, severely impairing the application procedure for clinical studies in all\u2026<\/p>\n","protected":false},"template":"","class_list":["post-6895","news-events-news","type-news-events-news","status-publish","hentry"],"yoast_head":"\nMartin Krauss on how CTIS endangers the future of clinical studies in Europe - FGK Group<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fgk-group.com\/de\/news-konferenzen\/news\/martin-krauss-on-how-ctis-endangers-the-future-of-clinical-studies-in-europe\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Martin Krauss on how CTIS endangers the future of clinical studies in Europe - FGK Group\" \/>\n<meta property=\"og:description\" content=\"One year after its launch, the CTIS portal suffers from serious deficiencies, severely impairing the application procedure for clinical studies in all\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fgk-group.com\/de\/news-konferenzen\/news\/martin-krauss-on-how-ctis-endangers-the-future-of-clinical-studies-in-europe\/\" \/>\n<meta property=\"og:site_name\" content=\"FGK Group\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-20T10:44:56+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/news-konferenzen\\\/news\\\/martin-krauss-on-how-ctis-endangers-the-future-of-clinical-studies-in-europe\\\/\",\"url\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/news-konferenzen\\\/news\\\/martin-krauss-on-how-ctis-endangers-the-future-of-clinical-studies-in-europe\\\/\",\"name\":\"Martin Krauss on how CTIS endangers the future of clinical studies in Europe - FGK Group\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/#website\"},\"datePublished\":\"2025-09-08T04:53:06+00:00\",\"dateModified\":\"2025-11-20T10:44:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/news-konferenzen\\\/news\\\/martin-krauss-on-how-ctis-endangers-the-future-of-clinical-studies-in-europe\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fgk-group.com\\\/de\\\/news-konferenzen\\\/news\\\/martin-krauss-on-how-ctis-endangers-the-future-of-clinical-studies-in-europe\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/news-konferenzen\\\/news\\\/martin-krauss-on-how-ctis-endangers-the-future-of-clinical-studies-in-europe\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/news-konferenzen\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Martin Krauss on how CTIS endangers the future of clinical studies in Europe\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/\",\"name\":\"FGK Group\",\"description\":\"Just another WordPress site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fgk-group.com\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Martin Krauss on how CTIS endangers the future of clinical studies in Europe - FGK Group","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fgk-group.com\/de\/news-konferenzen\/news\/martin-krauss-on-how-ctis-endangers-the-future-of-clinical-studies-in-europe\/","og_locale":"de_DE","og_type":"article","og_title":"Martin Krauss on how CTIS endangers the future of clinical studies in Europe - FGK Group","og_description":"One year after its launch, the CTIS portal suffers from serious deficiencies, severely impairing the application procedure for clinical studies in all\u2026","og_url":"https:\/\/fgk-group.com\/de\/news-konferenzen\/news\/martin-krauss-on-how-ctis-endangers-the-future-of-clinical-studies-in-europe\/","og_site_name":"FGK Group","article_modified_time":"2025-11-20T10:44:56+00:00","twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/fgk-group.com\/de\/news-konferenzen\/news\/martin-krauss-on-how-ctis-endangers-the-future-of-clinical-studies-in-europe\/","url":"https:\/\/fgk-group.com\/de\/news-konferenzen\/news\/martin-krauss-on-how-ctis-endangers-the-future-of-clinical-studies-in-europe\/","name":"Martin Krauss on how CTIS endangers the future of clinical studies in Europe - FGK Group","isPartOf":{"@id":"https:\/\/fgk-group.com\/de\/#website"},"datePublished":"2025-09-08T04:53:06+00:00","dateModified":"2025-11-20T10:44:56+00:00","breadcrumb":{"@id":"https:\/\/fgk-group.com\/de\/news-konferenzen\/news\/martin-krauss-on-how-ctis-endangers-the-future-of-clinical-studies-in-europe\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fgk-group.com\/de\/news-konferenzen\/news\/martin-krauss-on-how-ctis-endangers-the-future-of-clinical-studies-in-europe\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/fgk-group.com\/de\/news-konferenzen\/news\/martin-krauss-on-how-ctis-endangers-the-future-of-clinical-studies-in-europe\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fgk-group.com\/de\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/fgk-group.com\/de\/news-konferenzen\/news\/"},{"@type":"ListItem","position":3,"name":"Martin Krauss on how CTIS endangers the future of clinical studies in Europe"}]},{"@type":"WebSite","@id":"https:\/\/fgk-group.com\/de\/#website","url":"https:\/\/fgk-group.com\/de\/","name":"FGK Group","description":"Just another WordPress site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fgk-group.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"}]}},"_links":{"self":[{"href":"https:\/\/fgk-group.com\/de\/wp-json\/wp\/v2\/news-events-news\/6895","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fgk-group.com\/de\/wp-json\/wp\/v2\/news-events-news"}],"about":[{"href":"https:\/\/fgk-group.com\/de\/wp-json\/wp\/v2\/types\/news-events-news"}],"version-history":[{"count":4,"href":"https:\/\/fgk-group.com\/de\/wp-json\/wp\/v2\/news-events-news\/6895\/revisions"}],"predecessor-version":[{"id":6900,"href":"https:\/\/fgk-group.com\/de\/wp-json\/wp\/v2\/news-events-news\/6895\/revisions\/6900"}],"wp:attachment":[{"href":"https:\/\/fgk-group.com\/de\/wp-json\/wp\/v2\/media?parent=6895"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}